Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GR270773 in Gram-negative severe sepsis (LIPOS)
NCT00089986Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2004
- Primary completion
- Apr 2007
- Modality
- Nanoparticles
- Countries
- 34
01
Overview
A Phase 2 trial of GR270773 in sepsis, Gram-negative bacterial infection, sponsored by GSK. Started Sep 2004; status: completed.
02
Drugs
GR270773
03
Conditions
sepsisGram-negative bacterial infection
Beyond the preview
Go deeper on NCT00089986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00089986.